Literature DB >> 23539537

Insights into pathological mechanisms of missense mutations in C-terminal domains of von Willebrand factor causing qualitative or quantitative von Willebrand disease.

Hamideh Yadegari1, Julia Driesen, Anna Pavlova, Arijit Biswas, Vytautas Ivaskevicius, Robert Klamroth, Johannes Oldenburg.   

Abstract

The carboxyl-terminal domains of von Willebrand factor, D4-CK, are cysteine-rich implying that they are structurally important. In this study we characterized the impact of five cysteine missense mutations residing in D4-CK domains on the conformation and biosynthesis of von Willebrand factor. These variants were identified as heterozygous in type 1 (p.Cys2619Tyr and p.Cys2676Phe), type 2A (p.Cys2085Tyr and p.Cys2327Trp) and as compound heterozygous in type 3 (p.Cys2283Arg) von Willebrand disease. Transient expression of human cell lines with wild-type or mutant von Willebrand factor constructs was performed. The mutated and wild-type recombinant von Willebrand factors were quantitatively and qualitatively assessed and compared. Storage of von Willebrand factor in pseudo-Weibel-Palade bodies was studied with confocal microscopy. The structural impact of the mutations was analyzed by homology modeling. Homozygous expressions showed that these mutations caused defects in multimerization, elongation of pseudo-Weibel-Palade bodies and secretion of von Willebrand factor. Co-expressions of wild-type von Willebrand factor and p.Cys2085Tyr, p.Cys2327Trp and p.Cys2283Arg demonstrated defective multimer assembly, suggesting a new pathological mechanism for dominant type 2A von Willebrand disease due to mutations in D4 and B domains. Structural analysis revealed that mutations p.Cys2283Arg, p.Cys2619Tyr and p.Cys2676Phe disrupted intra-domain disulfide bonds, whereas p.Cys2327Trp might affect an inter-domain disulfide bond. The p.Cys2327Trp variant is distinguished from the other mutants by an electrophoretic mobility shift of the multimer bands. The results highlight the importance of cysteine residues within the carboxyl-terminal of von Willebrand factor on structural conformation of the protein and consequently multimerization, storage, and secretion of von Willebrand factor.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23539537      PMCID: PMC3729914          DOI: 10.3324/haematol.2013.084111

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


  37 in total

1.  Increasing the precision of comparative models with YASARA NOVA--a self-parameterizing force field.

Authors:  Elmar Krieger; Günther Koraimann; Gert Vriend
Journal:  Proteins       Date:  2002-05-15

Review 2.  Von Willebrand's disease in the year 2003: towards the complete identification of gene defects for correct diagnosis and treatment.

Authors:  Giancarlo Castaman; Augusto B Federici; Francesco Rodeghiero; Pier Mannuccio Mannucci
Journal:  Haematologica       Date:  2003-01       Impact factor: 9.941

3.  A graphical interface for the FoldX forcefield.

Authors:  Joost Van Durme; Javier Delgado; Francois Stricher; Luis Serrano; Joost Schymkowitz; Frederic Rousseau
Journal:  Bioinformatics       Date:  2011-04-19       Impact factor: 6.937

4.  Intersection of mechanisms of type 2A VWD through defects in VWF multimerization, secretion, ADAMTS-13 susceptibility, and regulated storage.

Authors:  Paula M Jacobi; Joan Cox Gill; Veronica H Flood; David A Jakab; Kenneth D Friedman; Sandra L Haberichter
Journal:  Blood       Date:  2012-03-19       Impact factor: 22.113

5.  Allosteric disulfide bonds.

Authors:  Bryan Schmidt; Lorraine Ho; Philip J Hogg
Journal:  Biochemistry       Date:  2006-06-20       Impact factor: 3.162

Review 6.  Genotype/phenotype association in von Willebrand disease: is the glass half full or empty?

Authors:  D Lillicrap
Journal:  J Thromb Haemost       Date:  2009-07       Impact factor: 5.824

Review 7.  Biochemistry and genetics of von Willebrand factor.

Authors:  J E Sadler
Journal:  Annu Rev Biochem       Date:  1998       Impact factor: 23.643

8.  Recombinant expression of mutations causing von Willebrand disease type Normandy: characterization of a combined defect of factor VIII binding and multimerization.

Authors:  Reinhard Schneppenheim; Harald Lenk; Tobias Obser; Johannes Oldenburg; Florian Oyen; Sonja Schneppenheim; Rainer Schwaab; Kerstin Will; Ulrich Budde
Journal:  Thromb Haemost       Date:  2004-07       Impact factor: 5.249

9.  Analysis of intracellular storage and regulated secretion of 3 von Willebrand disease-causing variants of von Willebrand factor.

Authors:  Grégoire Michaux; Lindsay J Hewlett; Sarah L Messenger; Anne C Goodeve; Ian R Peake; Martina E Daly; Daniel F Cutler
Journal:  Blood       Date:  2003-06-05       Impact factor: 22.113

10.  LOMETS: a local meta-threading-server for protein structure prediction.

Authors:  Sitao Wu; Yang Zhang
Journal:  Nucleic Acids Res       Date:  2007-05-03       Impact factor: 16.971

View more
  6 in total

1.  Intron retention resulting from a silent mutation in the VWF gene that structurally influences the 5' splice site.

Authors:  Hamideh Yadegari; Arijit Biswas; Mohammad Suhail Akhter; Julia Driesen; Vytautas Ivaskevicius; Natascha Marquardt; Johannes Oldenburg
Journal:  Blood       Date:  2016-08-19       Impact factor: 22.113

2.  Identification of extant vertebrate Myxine glutinosa VWF: evolutionary conservation of primary hemostasis.

Authors:  Marianne A Grant; David L Beeler; Katherine C Spokes; Junmei Chen; Harita Dharaneeswaran; Tracey E Sciuto; Ann M Dvorak; Gianluca Interlandi; José A Lopez; William C Aird
Journal:  Blood       Date:  2017-09-12       Impact factor: 22.113

3.  Multifaceted pathomolecular mechanism of a VWF large deletion involved in the pathogenesis of severe VWD.

Authors:  Hamideh Yadegari; Muhammad Ahmer Jamil; Jens Müller; Natascha Marquardt; Orla Rawley; Ulrich Budde; Osman El-Maarri; David Lillicrap; Johannes Oldenburg
Journal:  Blood Adv       Date:  2022-02-08

4.  Genotypes of European and Iranian patients with type 3 von Willebrand disease enrolled in 3WINTERS-IPS.

Authors:  Luciano Baronciani; Ian Peake; Reinhard Schneppenheim; Anne Goodeve; Minoo Ahmadinejad; Zahra Badiee; Mohammad-Reza Baghaipour; Olga Benitez; Imre Bodó; Ulrich Budde; Andrea Cairo; Giancarlo Castaman; Peyman Eshghi; Jenny Goudemand; Wolf Hassenpflug; Hamid Hoorfar; Mehran Karimi; Bijan Keikhaei; Riitta Lassila; Frank W G Leebeek; Maria Fernanda Lopez Fernandez; Pier Mannuccio Mannucci; Renato Marino; Nikolas Nikšić; Florian Oyen; Cristina Santoro; Andreas Tiede; Gholamreza Toogeh; Alberto Tosetto; Marc Trossaert; Eva M K Zetterberg; Jeroen Eikenboom; Augusto B Federici; Flora Peyvandi
Journal:  Blood Adv       Date:  2021-08-10

5.  ATZ11 recognizes not only Z-α1-antitrypsin-polymers and complexed forms of non-Z-α1-antitrypsin but also the von Willebrand factor.

Authors:  Diane Goltz; Kanishka Hittetiya; Hamideh Yadegari; Julia Driesen; Jutta Kirfel; Thomas Neuhaus; Susanne Steiner; Christiane Esch; Jörg Bedorf; Hans-Jörg Hertfelder; Hans-Peter Fischer
Journal:  PLoS One       Date:  2014-03-19       Impact factor: 3.240

6.  A Homozygous Deep Intronic Variant Causes Von Willebrand Factor Deficiency and Lack of Endothelial-Specific Secretory Organelles, Weibel-Palade Bodies.

Authors:  Hamideh Yadegari; Muhammad Ahmer Jamil; Natascha Marquardt; Johannes Oldenburg
Journal:  Int J Mol Sci       Date:  2022-03-13       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.